Pulse Biosciences
PLSE
55 hedge funds and large institutions have $86.7M invested in Pulse Biosciences in 2021 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 15 reducing their positions, and 5 closing their positions.
107% more call options, than puts
Call options by funds: $2.17M | Put options by funds: $1.05M
70% more capital invested
Capital invested by funds: $51M → $86.7M (+$35.7M)
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
27% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 15
1.98% more ownership
Funds ownership: 11.9% → 13.88% (+2%)
2% more funds holding
Funds holding: 54 → 55 (+1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$16.3M |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$7.87M |
| 3 |
MGIM
M&G Investment Management
London,
United Kingdom
|
+$1.4M |
| 4 |
New York State Common Retirement Fund
Albany,
New York
|
+$412K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$146K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$2.09M |
| 2 |
Two Sigma Investments
New York
|
-$1.08M |
| 3 |
BlackRock
New York
|
-$864K |
| 4 |
Renaissance Technologies
New York
|
-$654K |
| 5 |
Millennium Management
New York
|
-$288K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MGIM
51
M&G Investment Management
London,
United Kingdom
| $1.43K | +$1.4M | +65,132 | New |
|
|
CP
52
Corbenic Partners
Bethlehem,
Pennsylvania
| $1K | – | – | – |
|
53
PNC Financial Services Group
Pittsburgh,
Pennsylvania
| $1K | – | – | – |
|
|
WIM
54
Westside Investment Management
Santa Monica,
California
| $737 | +$4.91K | +228 | +0.7% |
|
55
Nisa Investment Advisors
St. Louis,
Missouri
| $9 | – | – | – |
|
|
56
Renaissance Technologies
New York
| – | -$654K | -39,852 | Closed |
|
|
57
Millennium Management
New York
| – | -$288K | -17,535 | Closed |
|
58
D.E. Shaw & Co
New York
| – | -$287K | -17,528 | Closed |
|
|
WOC
59
West Oak Capital
Westlake Village,
California
| – | -$2K | -100 | Closed |
|
|
TFO
60
Tarbox Family Office
Newport Beach,
California
| – | -$1K | -52 | Closed |
|
PLSE Hedge Fund Activity: Q3 2021 in Review
55 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q3 2021, worth a combined $86.7M — up 70% from $51M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new PLSE positions and 5 closed out — a net gain of 2 holders — while 19 added to existing stakes and 15 trimmed.
The largest buyer was Bank of America, adding an estimated $16.3M. The largest seller was Morgan Stanley, cutting an estimated $2.09M.
- 55 institutional investors held Pulse Biosciences (PLSE) as of Q3 2021, up from 54 in Q2 2021.
- Funds reported $86.7M of Pulse Biosciences stock for Q3 2021, up 70% quarter-over-quarter.
- 7 funds opened new Pulse Biosciences positions in Q3 2021 and 5 closed out, a net change of +2 holders.
- The largest Pulse Biosciences buyer in Q3 2021 was Bank of America, an estimated $16.3M added.
- The largest Pulse Biosciences seller in Q3 2021 was Morgan Stanley, an estimated $2.09M sold.
Based on aggregated 13F filings for Q3 2021.